Overview

Study of SPARC1103 in Subjects With Spasticity

Status:
Completed
Trial end date:
2017-04-28
Target enrollment:
Participant gender:
Summary
Study of SPARC1103 in subjects with spasticity
Phase:
Phase 2
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited